Fort Madison Daily Democrat
Pfizer Invites Public to Listen to Webcast of April 25 Annual Meeting of Shareholders
Southeast Iowa
•
Apr 18, 2019
Pfizer
Latest Iowa stories tagged “Pfizer”.
Fort Madison Daily Democrat
Oelwein Daily Register
Pfizer Invites Public to Listen to Webcast of April 25 Annual Meeting of Shareholders
Northeast Iowa
•
Apr 18, 2019
Fort Madison Daily Democrat
Pfizer Announces Presentation of Data from a Phase 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive...
Southeast Iowa
•
Apr 13, 2019
Oelwein Daily Register
Pfizer Announces Presentation of Data from a Phase 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive...
Northeast Iowa
•
Apr 13, 2019
Fort Madison Daily Democrat
Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy
Southeast Iowa
•
Apr 2, 2019
Oelwein Daily Register
Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy
Northeast Iowa
•
Apr 2, 2019
Oelwein Daily Register
Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics
Northeast Iowa
•
Mar 20, 2019
Fort Madison Daily Democrat
U.S. FDA Approves Pfizer's Oncology Biosimilar TRAZIMERA (trastuzumab-qyyp), a Biosimilar to Herceptin1
Southeast Iowa
•
Mar 12, 2019
Oelwein Daily Register
U.S. FDA Approves Pfizer's Oncology Biosimilar TRAZIMERA (trastuzumab-qyyp), a Biosimilar to Herceptin1
Northeast Iowa
•
Mar 12, 2019
Oelwein Daily Register
Pfizer Receives Positive CHMP Opinion for LORVIQUA (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer
Northeast Iowa
•
Mar 1, 2019
Keokuk Daily Gate City
Pfizer Receives Positive CHMP Opinion for LORVIQUA (lorlatinib) for Certain Adult Patients with Previously-Treated ALK-Positive Advanced Non-Small Cell Lung Cancer
Southeast Iowa
•
Mar 1, 2019
Fort Madison Daily Democrat
Pfizer Receives European Approval for ZIRABEV (bevacizumab), a Biosimilar to Avastin*
Southeast Iowa
•
Feb 19, 2019
Oelwein Daily Register
Pfizer Receives European Approval for ZIRABEV (bevacizumab), a Biosimilar to Avastin*
Northeast Iowa
•
Feb 19, 2019
Clinton Herald
Pfizer swings to loss due to restructuring, asset writedowns
Eastern Iowa
•
Jan 29, 2019